Literature DB >> 1558783

Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy.

K W Woodburn1, S Stylli, J S Hill, A H Kaye, J A Reiss, D R Phillips.   

Abstract

A range of pure, monomeric porphyrins were synthesised and their localising capacities compared to HpD and Hp at 6 h and 24 h post injection in the mouse C6 intracerebral glioma model as well as in normal brain, skin, muscle, kidney, spleen, liver, lung and whole blood. The partition coefficients were examined between PBS and 2-octanol over the pH range 7.4-6.6 and pH profiles were established. A parabolic relationship was observed between log (porphyrin tumour concentration) at pH 7.4, with maximal tumour localisation at log (partition coefficient), pi, of approximately zero. Porphyrins with side chains with nett cationic character also exhibited up upward (parabolic) dependence on pi for most tissues studied, with maximal porphyrin localisation at pi of 0-0.5. In contrast, those porphyrins with nett anionic character exhibited a downward (negative) parabolic trend for all eight tissues studied, with minimal porphyrin localisation at pi of approximately zero. Four porphyrins (4, 11, 12, 13) exhibited similar or better tumour localisation than HpD, and two (11 and 12) offer promise as lead compounds for the design of improved porphyrins for use in PDT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558783      PMCID: PMC1977589          DOI: 10.1038/bjc.1992.66

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cells.

Authors:  D Kessel
Journal:  Biochemistry       Date:  1977-07-26       Impact factor: 3.162

2.  Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain.

Authors:  P J Muller; B C Wilson
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

3.  Porphyrin-lipoprotein association as a factor in porphyrin localization.

Authors:  D Kessel
Journal:  Cancer Lett       Date:  1986-11       Impact factor: 8.679

4.  Studies on the structure of porphyrins contained in Photofrin II.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

5.  Biological and biophysical properties of the tumor-localizing component of hematoporphyrin derivative.

Authors:  D Kessel; M L Cheng
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

6.  A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.

Authors:  Y C Martin
Journal:  J Med Chem       Date:  1981-03       Impact factor: 7.446

7.  Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer.

Authors:  J Moan; Q Peng; J F Evensen; K Berg; A Western; C Rimington
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

Review 8.  Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction.

Authors:  B W Henderson; D A Bellnier
Journal:  Ciba Found Symp       Date:  1989

9.  Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative.

Authors:  J P Thomas; A W Girotti
Journal:  Photochem Photobiol       Date:  1989-03       Impact factor: 3.421

10.  Selective in vivo tumor localization of uroporphyrin isomer I in mouse mammary carcinoma: superiority over other porphyrins in a comparative study.

Authors:  M A el-Far; N R Pimstone
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

View more
  9 in total

1.  Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.

Authors:  T Maisch; C Bosl; R-M Szeimies; N Lehn; C Abels
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

3.  Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes.

Authors:  Fabio M Engelmann; Ildemar Mayer; Dino S Gabrielli; Henrique E Toma; Alicia J Kowaltowski; Koiti Araki; Mauricio S Baptista
Journal:  J Bioenerg Biomembr       Date:  2007-04-14       Impact factor: 3.853

4.  Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy.

Authors:  K W Woodburn; J S Hill; S Stylli; A H Kaye; J A Reiss; D R Phillips
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

5.  Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer.

Authors:  M R Hamblin; M Del Governatore; I Rizvi; T Hasan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  Cell-Penetrating Protein/Corrole Nanoparticles.

Authors:  Matan Soll; Tridib K Goswami; Qiu-Cheng Chen; Irena Saltsman; Ruijie D Teo; Mona Shahgholi; Punnajit Lim; Angel J Di Bilio; Sarah Cohen; John Termini; Harry B Gray; Zeev Gross
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

7.  Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice.

Authors:  S L Gibson; T H Foster; R H Feins; R F Raubertas; M A Fallon; R Hilf
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

8.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.